Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MEDTRONIC PLC

(MDT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medtronic : Says US Patent Office Rejects Axonics' Challenge to Bladder Device Patents

09/14/2021 | 05:03am EDT


© MT Newswires 2021
All news about MEDTRONIC PLC
10/22MEDTRONIC : Austin L. Chiang, M.D., M.P.H. joins Medtronic as Chief Medical Officer for Ga..
AQ
10/21Austin L. Chiang, M.D., M.P.H. Joins Medtronic as Chief Medical Officer for Gastrointes..
CI
10/19MEDTRONIC : Children achieve Time in Range mirroring well-controlled adults for the first ..
PR
10/19Medtronic plc Announces Children achieve Time in Range mirroring well-controlled adults..
CI
10/18MEDTRONIC : Shares Down Midday After DSMB Recommends Continued Enrollment of Symplicity Tr..
MT
10/18MEDTRONIC : Wells Fargo Adjusts Price Taget on Medtronic to $144 from $151, Keeps Overweig..
MT
10/18Medtronic Plc Down Over 5%, On Pace for Largest Percent Decrease Since June 2020 -- Dat..
DJ
10/17Medtronic Reportedly in Talks to Buy Insulin Pump Patch Maker Triple Jump
CI
10/15MEDTRONIC PLC : Regulation FD Disclosure (form 8-K)
AQ
10/13OPSENS : Says "Successfully Treats" First Patients in Human Clinical Study for TAVR Proced..
MT
More news
Analyst Recommendations on MEDTRONIC PLC
More recommendations
Financials (USD)
Sales 2022 32 990 M - -
Net income 2022 5 614 M - -
Net Debt 2022 20 291 M - -
P/E ratio 2022 31,1x
Yield 2022 1,95%
Capitalization 166 B 166 B -
EV / Sales 2022 5,64x
EV / Sales 2023 5,29x
Nbr of Employees 90 000
Free-Float 99,7%
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 28
Last Close Price 123,09 $
Average target price 145,52 $
Spread / Average Target 18,2%
EPS Revisions
Managers and Directors
Geoffrey Straub Martha Chairman & Chief Executive Officer
Karen L. Parkhill Chief Financial Officer & Executive Vice President
Laura Mauri Chief Clinical & Regulatory Officer, Senior VP
Richard E. Kuntz Chief Medical & Scientific Officer, Senior VP
Gregory L. Smith Executive VP-Global Operations & Supply Chain
Sector and Competitors
1st jan.Capi. (M$)
MEDTRONIC PLC5.08%165 656
ABBOTT LABORATORIES15.74%224 651
BECTON, DICKINSON AND COMPANY-1.25%70 962
HOYA CORPORATION21.65%56 316
DEXCOM, INC.53.24%54 815
SARTORIUS STEDIM BIOTECH64.49%51 360